| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |